Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain

NDT Plus

Volumn 3, Issue SUPPLL. 2, 2010, Pages

  Hernández, Ángel Alonso ^a   Moreso, Francesc ^b   Bayés, Beatriz ^c   Lauzurica, Ricardo ^c   Sánz Guajardo, Dámaso ^d   Gómez Huertas, Ernesto ^e   Pereira, Porfirio ^f   Paul, Javier ^g   Crespo, Josep ^h   Amenábar, Juan J ⁱ   Oliver, Juan ^a   Serón, Daniel ^b  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^h Hospital Peset   (Spain)

ⁱ HOSPITAL DE CRUCES   (Spain)

Author keywords

angiotensin receptor blockers; angiotensin converting enzyme inhibitors; graft survival; renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SPAIN; SURVIVAL RATE;

EID: 77956023081     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq068     Document Type: Article

References (17)

1. Brenner BM, Cooper ME, de Zeeuw et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869
2. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensinconverting enzyme-inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
3. Cohen DL, Townsend RR. Is there value to adding ARB to ACE inhibitors in the management of CKD?. J Am Soc Nephrol 2009; 20: 1666-1668
4. Hiremath S, Fergusson D, Doucette S et al. Renin-angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007; 7: 2350-2360
5. El-Agroudy AE, Hassan NA, Foda MA et al. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol 2003; 23: 300-306
6. Artz MA, Hilbrands LB, Borm G et al. Blockade of the renin-angiotensin system increases graft survival in patients with chron-ic allograft nephropathy. Nephrol Dial Transplant 2004; 19: 2852-2857
7. Heinze G, Mitterbauer C, Regele H et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889-899
8. Zaltzmam JS, Nash M, Chiu R et al. The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy. Nephrol Dial Transplant 2004; 19: 940-944
9. Opelz G, Zeier M, Laux G et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 2006; 17: 3257-3262
10. Palmer BF.. Managing hyperkalemia caused by inhibitors of the rennin-angiotensin-aldosterone system. N Engl J Med 2004; 351: 585-592
11. Karthikeyan V, Karpinski J, Nair RC et al. The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004; 4: 262-269
12. Wormer KL, Vella JP, Sayegh MH et al. Chronic allograft dysfunction: mechanisms and new approaches to therapy. Semin Nephrol 2000; 20: 126-147
13. Seron D, Moreso F, Grinyo JM. Prevention and management of late renal allograft dysfunction. J Nephrol 2001; 14: 71-79
14. Stigant CE, Cohen J, Vivera BS et al. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 2000; 35: 58-63
15. Lin J, Valeri A, Markowitz GS et al. Angiotensin-converting enzyme inhibition in chronic allograft nephropathy. Transplantation 2002; 73: 783-788
16. Tutone VK, Mark PB, Stewart GA et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 2005; 19: 181-192
17. Amara AB, Sharma A, Alexander JL et al. Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy. Transplantation 2010; 89: 104-114